Telomerase activity assay for the diagnosis of malignant pleural effusion: A meta-analysis

Experimental and Therapeutic Medicine

Volumn 4, Issue 3, 2012, Pages 487-492

  Shen, Yong Chun ^a   Chen, Zhen Ni ^b   Yang, Ting ^a   Chen, Lei ^a   Wang, Tao ^a   Wen, Fu Qiang ^a   Yi, Qun ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Center for Disease Control and Prevention   (China)

Author keywords

Malignant pleural effusion; Meta analysis; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; EMBASE; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; MALIGNANT PLEURAL EFFUSION; MEDLINE; META ANALYSIS; PLEURA EFFUSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84863980038     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.623     Document Type: Article

References (35)

1. Light RW: Pleural effusions. Med Clin North Am 95: 1055-1070, 2011.
2. Bennett R and Maskell N: Management of malignant pleural effusions. Curr Opin Pulm Med 11: 296-300, 2005.
3. McGrath EE and Anderson PB: Diagnosis of pleural effusion: a systematic approach. Am J Crit Care 20: 119-127, 2011.
4. Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G and Pastorelli D: Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J Clin Oncol 33: 420-423, 2010.
5. Shen YC, Liu MQ, Wan C, Chen L, Wang T and Wen FQ: Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion. Exp Ther Med: March 14, 2012 (Epub ahead of print).
6. Shi HZ, Liang QL, Jiang J, Qin XJ and Yang HB: Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 13: 518-527, 2008.
7. Liang QL, Shi HZ, Qin XJ, Liang XD, Jiang J and Yang HB: Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 63: 35-41, 2008.
8. Zvereva MI, Shcherbakova DM and Dontsova OA: Telomerase: structure, functions, and activity regulation. Biochemistry (Mosc) 75: 1563-1583, 2010.
9. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 87: 884-894, 1995.
10. Chen CH and Chen RJ: Prevalence of telomerase activity in human cancer. J Formos Med Assoc 110: 275-289, 2011.
11. Ouellette MM, Wright WE and Shay JW: Targeting telomerase-expressing cancer cells. J Cell Mol Med 15: 1433-1442, 2011.
12. Heaphy CM and Meeker AK: The potential utility of telomere-related markers for cancer diagnosis. J Cell Mol Med 15: 1227-1238, 2011.
13. Tangkijvanich P, Tresukosol D, Sampatanukul P, et al: Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res 5: 2470-2475, 1999.
14. Braunschweig R, Yan P, Guilleret I, et al: Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 24: 174-180, 2001.
15. Moher D, Liberati A, Tetzlaff J and Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097, 2009.
16. Leeflang MM, Deeks JJ, Gatsonis C and Bossuyt PM; Cochrane Diagnostic Test Accuracy Working Group: Systematic reviews of diagnostic test accuracy. Ann Intern Med 149: 889-897, 2008.
17. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN and Kleijnen J: Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6: 9, 2006.
18. Devillé WL, Buntinx F, Bouter LM, et al: Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2: 9, 2002.
19. Moses LE, Shapiro D and Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12: 1293-1316, 1993.
20. Deeks JJ, Macaskill P and Irwig L: The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58: 882-893, 2005.
21. Yang CT, Lee MH, Lan RS and Chen JK: Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol 16: 567-573, 1998.
22. Yang Z and Xie C: Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions. Zhonghua Jie He He Hu Xi Za Zhi 24: 201-203, 2001 (In Chinese).
23. Dikmen G, Dikmen E, Kara M, Sahin E, Doǧan P and Ozdemir N: Diagnostic implications of telomerase activity in pleural effusions. Eur Respir J 22: 422-426, 2003.
24. Lee WY: Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Cytopathology 16: 227-232, 2005.
25. Maneechotesuwan K, Lertworawiwat A, Tscheikuna J and Wamanuttajinda V: Comparison of telomerase activity between malignant and tuberculous pleural effusions. J Med Assoc Thai 89: (Suppl 5) S46-54, 2006.
26. Li GB, Wang M, Guo S, Lü Y and Wang W: Value of combined pleural effusion testing of telomerase and CEA for differential diagnosis of malignant and nonmalignant pleural effusion. Chin J Cancer Prev Treat 15: 299-300, 318, 2008.
27. Mousavi SA, Bahari R and Karimi MA: Comparison of telomerase activity in malignant and benign pleural effusions. Tanaffos 8: 17-23, 2009.
28. Li H, Fu J, Xiu Y and Zhou Q: Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion. Zhongguo Fei Ai Za Zhi 13: 652-654, 2010 (In Chinese).
29. Walter SD: Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21: 1237-1256, 2002.
30. Jones CM and Athanasiou T: Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79: 16-20, 2005.
31. Glas AS, Lijmer JG, Prins MH, Bonsel GJ and Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135, 2003.
32. Stengel D, Bauwens K, Sehouli J, Ekkernkamp A and Porzsolt F: A likelihood ratio approach to meta-analysis of diagnostic studies. J Med Screen 10: 47-51, 2003.
33. Hansson M, Zendehrokh N, Ohyashiki J, et al: Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay. Arch Pathol Lab Med 132: 1896-1902, 2008.
34. Dejmek A, Yahata N, Ohyashiki K, et al: In situ telomerase activity in pleural effusions: a promising marker for malignancy. Diagn Cytopathol 24: 11-15, 2001.
35. Song F, Khan KS, Dinnes J and Sutton AJ: Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31: 88-95, 2002.